r individual patients by, for example, compounding and selling large quantities of drugs without meeting safety and quality and other requirements for new manufactured drugs, said Janet Heinrich, then FDA director of health care and public health issues.</p><p>The agency re-emphasized the point in a report to Congress in 2007.</p><p>Not all pharmacists have the same level of skills an